BrainStorm and Octane Biotech Announce Success in Cocoon Application Development Based on Customized Bioreactor for NurOwn® Stem Cells
December 01, 2015 at 08:10 AM EST
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, ...